OPUS NEXTGEN Trademark

Trademark Overview

On Tuesday, May 4, 2021, a trademark application was filed for OPUS NEXTGEN with the United States Patent and Trademark Office. The USPTO has given the OPUS NEXTGEN trademark a serial number of 90688853. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, March 25, 2023. This trademark is owned by CADENCE Rx. The OPUS NEXTGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service featuring computer software for use in pharmaceutical benefit management
opus nextgen

General Information

Serial Number90688853
Word MarkOPUS NEXTGEN
Filing DateTuesday, May 4, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, March 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkOPUS NEXT GEN
Goods and ServicesSoftware as a service featuring computer software for use in pharmaceutical benefit management

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 10, 2022
Primary Code042
First Use Anywhere DateMonday, June 1, 2020
First Use In Commerce DateMonday, June 1, 2020

Trademark Owner History

Party NameCADENCE Rx
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33609

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, March 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, March 25, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 31, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 9, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 19, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 19, 2022FINAL REFUSAL E-MAILED
Tuesday, April 19, 2022FINAL REFUSAL WRITTEN
Wednesday, March 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 15, 2022ASSIGNED TO LIE
Monday, March 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 11, 2022NON-FINAL ACTION E-MAILED
Tuesday, January 11, 2022NON-FINAL ACTION WRITTEN
Thursday, January 6, 2022ASSIGNED TO EXAMINER
Thursday, August 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 7, 2021NEW APPLICATION ENTERED

Related Keywords

nextgen opus software benefit management pharmaceutical computer service featuring